LDL-话题@MedSci - 梅斯（MedSci）

#LDL#

125篇内容 | 3428人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1422583, encodeId=8128142258397, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, objectTitle=【CHC2019】LDL-C降到极低水平，也存在一些潜在临床风险, objectType=article, longId=182679, objectId=245a1826e99b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=245a1826e99b, replyNumber=0, likeNumber=0, createdTime=2019-11-10, rootId=0, userName=zhwj, userId=382c3719677, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=245a1826e99b, moduleTitle=【CHC2019】LDL-C降到极低水平，也存在一些潜在临床风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=245a1826e99b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422582, encodeId=371a1422582e7, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, objectTitle=Circulation：LDL-C降低疗法——老年人心血管事件的一级预防, objectType=article, longId=179956, objectId=28a81e9956fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28a81e9956fe, replyNumber=0, likeNumber=107, createdTime=2019-09-25, rootId=0, userName=zhwj, userId=382c3719677, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28a81e9956fe, moduleTitle=Circulation：LDL-C降低疗法——老年人心血管事件的一级预防, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=28a81e9956fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422581, encodeId=2e29142258141, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, objectTitle=Clinica Chimica Acta：马丁方程对埃及2型糖尿病患者LDL-C估计的评价, objectType=article, longId=179883, objectId=57b81e9883d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57b81e9883d6, replyNumber=0, likeNumber=56, createdTime=2019-09-24, rootId=0, userName=zhwj, userId=382c3719677, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57b81e9883d6, moduleTitle=Clinica Chimica Acta：马丁方程对埃及2型糖尿病患者LDL-C估计的评价, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=57b81e9883d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422580, encodeId=325014225809a, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, objectTitle=Clinica Chimica Acta：弗里德瓦尔德公式计算的非空腹LDL-C水平与中国冠心病患者每日早餐后直接测量的LDL-C水平比较, objectType=article, longId=179877, objectId=2b991e987723, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b991e987723, replyNumber=0, likeNumber=62, createdTime=2019-09-24, rootId=0, userName=zhwj, userId=382c3719677, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b991e987723, moduleTitle=Clinica Chimica Acta：弗里德瓦尔德公式计算的非空腹LDL-C水平与中国冠心病患者每日早餐后直接测量的LDL-C水平比较, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2b991e987723)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422579, encodeId=5dbb14225e92e, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, objectTitle=ESC新血脂指南公布：LDL-C“低一点好一点”，他汀严重肌肉症状少见, objectType=article, longId=178641, objectId=cbeb1e8641dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbeb1e8641dc, replyNumber=0, likeNumber=76, createdTime=2019-09-04, rootId=0, userName=zhwj, userId=382c3719677, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbeb1e8641dc, moduleTitle=ESC新血脂指南公布：LDL-C“低一点好一点”，他汀严重肌肉症状少见, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cbeb1e8641dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422578, encodeId=be9714225e8a8, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, objectTitle=JACC：PCSK9基因突变引起的低LDL与更低的心血管死亡风险相关, objectType=article, longId=172191, objectId=afd31e21917b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afd31e21917b, replyNumber=0, likeNumber=75, createdTime=2019-06-27, rootId=0, userName=zhwj, userId=382c3719677, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afd31e21917b, moduleTitle=JACC：PCSK9基因突变引起的低LDL与更低的心血管死亡风险相关, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=afd31e21917b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422577, encodeId=c3cd14225e7e2, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, objectTitle=JCLA：血清oxLDL /β2-GPI复合物升高与2型糖尿病患者糖尿病微血管并发症相关, objectType=article, longId=167815, objectId=a4f416e81535, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4f416e81535, replyNumber=0, likeNumber=61, createdTime=2019-06-08, rootId=0, userName=zhwj, userId=382c3719677, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4f416e81535, moduleTitle=JCLA：血清oxLDL /β2-GPI复合物升高与2型糖尿病患者糖尿病微血管并发症相关, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a4f416e81535)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422576, encodeId=23e114225e68b, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, objectTitle=Neurology:“坏胆固醇LDL-C越低越好”受质疑，挑战PCSK9抑制剂安全性：Neurology杂志研究称，<70mg/dl脑出血风险增倍, objectType=article, longId=164741, objectId=43c5164e41c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43c5164e41c4, replyNumber=0, likeNumber=69, createdTime=2019-04-23, rootId=0, userName=zhwj, userId=382c3719677, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43c5164e41c4, moduleTitle=Neurology:“坏胆固醇LDL-C越低越好”受质疑，挑战PCSK9抑制剂安全性：Neurology杂志研究称，<70mg/dl脑出血风险增倍, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=43c5164e41c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422575, encodeId=7b9714225e5da, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, objectTitle=NEJM：新型降脂药物bempedoic acid安全有效的降低LDL胆固醇水平, objectType=article, longId=162567, objectId=61b816256efb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61b816256efb, replyNumber=0, likeNumber=78, createdTime=2019-03-20, rootId=0, userName=zhwj, userId=382c3719677, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61b816256efb, moduleTitle=NEJM：新型降脂药物bempedoic acid安全有效的降低LDL胆固醇水平, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=61b816256efb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422574, encodeId=aec614225e4f6, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, objectTitle=NEJM：Bempedoic acid降低LDL胆固醇的安全性和疗效, objectType=article, longId=162318, objectId=057a16231874, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=057a16231874, replyNumber=0, likeNumber=106, createdTime=2019-03-15, rootId=0, userName=zhwj, userId=382c3719677, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=057a16231874, moduleTitle=NEJM：Bempedoic acid降低LDL胆固醇的安全性和疗效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=057a16231874)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422573, encodeId=9fd714225e3cc, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, objectTitle=美国新版胆固醇指南十大要点：极高危患者LDL-C不能达到<1.8 mmol/L时，应依次使用依折麦布和PCSK9抑制剂, objectType=article, longId=153260, objectId=1aab1532607c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1aab1532607c, replyNumber=0, likeNumber=81, createdTime=2018-11-13, rootId=0, userName=zhwj, userId=382c3719677, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1aab1532607c, moduleTitle=美国新版胆固醇指南十大要点：极高危患者LDL-C不能达到<1.8 mmol/L时，应依次使用依折麦布和PCSK9抑制剂, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1aab1532607c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422572, encodeId=2f5e14225e244, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, objectTitle=JACC：血脂促进动脉粥样硬化观点-强调LDL-C累积暴露，终生最适LDL-C或为70~80 mg/dl, objectType=article, longId=151752, objectId=1b94151e52eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b94151e52eb, replyNumber=0, likeNumber=75, createdTime=2018-10-25, rootId=0, userName=zhwj, userId=382c3719677, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b94151e52eb, moduleTitle=JACC：血脂促进动脉粥样硬化观点-强调LDL-C累积暴露，终生最适LDL-C或为70~80 mg/dl, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1b94151e52eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422571, encodeId=447d14225e1ed, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, objectTitle=JACC：家族性高胆固醇血症基因检测共识：仅根据LDL-C升高判断，会漏诊相当一部分患者, objectType=article, longId=147175, objectId=dfaa14e17544, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfaa14e17544, replyNumber=0, likeNumber=71, createdTime=2018-08-23, rootId=0, userName=zhwj, userId=382c3719677, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfaa14e17544, moduleTitle=JACC：家族性高胆固醇血症基因检测共识：仅根据LDL-C升高判断，会漏诊相当一部分患者, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=dfaa14e17544)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422570, encodeId=558014225e082, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, objectTitle=JAMA Cardiol：全新血脂Meta分析支持LDL-C“越低越好”，临床获益来自降脂本身, objectType=article, longId=146073, objectId=79771460e36c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79771460e36c, replyNumber=0, likeNumber=59, createdTime=2018-08-09, rootId=0, userName=zhwj, userId=382c3719677, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79771460e36c, moduleTitle=JAMA Cardiol：全新血脂Meta分析支持LDL-C“越低越好”，临床获益来自降脂本身, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=79771460e36c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422569, encodeId=b63b1422569f8, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, objectTitle=Circulation：炎症是否会影响evolocumab降低LDL-C和心血管意外风险的效果？, objectType=article, longId=143114, objectId=03c114311490, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03c114311490, replyNumber=0, likeNumber=107, createdTime=2018-07-12, rootId=0, userName=zhwj, userId=382c3719677, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03c114311490, moduleTitle=Circulation：炎症是否会影响evolocumab降低LDL-C和心血管意外风险的效果？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=03c114311490)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422568, encodeId=a979142256827, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, objectTitle=Eur Heart J：二级预防他汀和非他汀类降LDL药对心血管结局有何影响？, objectType=article, longId=142637, objectId=40fa14263e8b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40fa14263e8b, replyNumber=0, likeNumber=67, createdTime=2018-07-08, rootId=0, userName=zhwj, userId=382c3719677, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40fa14263e8b, moduleTitle=Eur Heart J：二级预防他汀和非他汀类降LDL药对心血管结局有何影响？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=40fa14263e8b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422567, encodeId=a9e0142256e24, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, objectTitle=JACC：RLP-C和LDL-TG可以预测心血管事件的发生, objectType=article, longId=142623, objectId=1cd914262325, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1cd914262325, replyNumber=0, likeNumber=65, createdTime=2018-07-08, rootId=0, userName=zhwj, userId=382c3719677, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1cd914262325, moduleTitle=JACC：RLP-C和LDL-TG可以预测心血管事件的发生, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1cd914262325)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422566, encodeId=6e611422566c9, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, objectTitle=OCC2018 | 梁春：独立于降低LDL-C的抗炎治疗，开启抗动脉粥样硬化精准治疗新纪元——CANTOS研究解读, objectType=article, longId=139992, objectId=d13e13999200, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d13e13999200, replyNumber=0, likeNumber=53, createdTime=2018-06-06, rootId=0, userName=zhwj, userId=382c3719677, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d13e13999200, moduleTitle=OCC2018 | 梁春：独立于降低LDL-C的抗炎治疗，开启抗动脉粥样硬化精准治疗新纪元——CANTOS研究解读, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d13e13999200)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422565, encodeId=0a0f14225655a, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, objectTitle=Circulation：必须对LDL-C下狠手了！迄今很大、亚洲临床研究证实，高剂量他汀对亚洲人心血管疾病的二级预防更有效, objectType=article, longId=137614, objectId=873b13e614c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=873b13e614c3, replyNumber=0, likeNumber=63, createdTime=2018-05-10, rootId=0, userName=zhwj, userId=382c3719677, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=873b13e614c3, moduleTitle=Circulation：必须对LDL-C下狠手了！迄今很大、亚洲临床研究证实，高剂量他汀对亚洲人心血管疾病的二级预防更有效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=873b13e614c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422564, encodeId=9c711422564b5, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, objectTitle=JAMA：基线LDL水平影响调脂药物的疗效, objectType=article, longId=137468, objectId=c79d13e4687d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c79d13e4687d, replyNumber=0, likeNumber=60, createdTime=2018-05-09, rootId=0, userName=zhwj, userId=382c3719677, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c79d13e4687d, moduleTitle=JAMA：基线LDL水平影响调脂药物的疗效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c79d13e4687d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

LDL

2020-05-29

zhwj (审核中...)

前往app查看评论内容

#LDL#

【CHC2019】LDL-C降到极低水平，也存在一些潜在临床风险

2019-11-10

zhwj (审核中...)

前往app查看评论内容

#LDL#

Circulation：LDL-C降低疗法——老年人心血管事件的一级预防

2019-09-25

zhwj (审核中...)

前往app查看评论内容

#LDL#

Clinica Chimica Acta：马丁方程对埃及2型糖尿病患者LDL-C估计的评价

2019-09-24

zhwj (审核中...)

前往app查看评论内容

#LDL#

Clinica Chimica Acta：弗里德瓦尔德公式计算的非空腹LDL-C水平与中国冠心病患者每日早餐后直接测量的LDL-C水平比较

2019-09-24

zhwj (审核中...)

前往app查看评论内容

#LDL#

ESC新血脂指南公布：LDL-C“低一点好一点”，他汀严重肌肉症状少见

2019-09-04

zhwj (审核中...)

前往app查看评论内容

#LDL#

JACC：PCSK9基因突变引起的低LDL与更低的心血管死亡风险相关

2019-06-27

zhwj (审核中...)

前往app查看评论内容

#LDL#

JCLA：血清oxLDL /β2-GPI复合物升高与2型糖尿病患者糖尿病微血管并发症相关

2019-06-08

zhwj (审核中...)

前往app查看评论内容

#LDL#

Neurology:“坏胆固醇LDL-C越低越好”受质疑，挑战PCSK9抑制剂安全性：Neurology杂志研究称，<70mg/dl脑出血风险增倍

2019-04-23

zhwj (审核中...)

前往app查看评论内容

#LDL#

NEJM：新型降脂药物bempedoic acid安全有效的降低LDL胆固醇水平

2019-03-20

zhwj (审核中...)

前往app查看评论内容

#LDL#

NEJM：Bempedoic acid降低LDL胆固醇的安全性和疗效

2019-03-15

zhwj (审核中...)

前往app查看评论内容

#LDL#

美国新版胆固醇指南十大要点：极高危患者LDL-C不能达到<1.8 mmol/L时，应依次使用依折麦布和PCSK9抑制剂

2018-11-13

zhwj (审核中...)

前往app查看评论内容

#LDL#

JACC：血脂促进动脉粥样硬化观点-强调LDL-C累积暴露，终生最适LDL-C或为70~80 mg/dl

2018-10-25

zhwj (审核中...)

前往app查看评论内容

#LDL#

JACC：家族性高胆固醇血症基因检测共识：仅根据LDL-C升高判断，会漏诊相当一部分患者

2018-08-23

zhwj (审核中...)

前往app查看评论内容

#LDL#

JAMA Cardiol：全新血脂Meta分析支持LDL-C“越低越好”，临床获益来自降脂本身

2018-08-09

zhwj (审核中...)

前往app查看评论内容

#LDL#

Circulation：炎症是否会影响evolocumab降低LDL-C和心血管意外风险的效果？

2018-07-12

zhwj (审核中...)

前往app查看评论内容

#LDL#

Eur Heart J：二级预防他汀和非他汀类降LDL药对心血管结局有何影响？

2018-07-08

zhwj (审核中...)

前往app查看评论内容

#LDL#

JACC：RLP-C和LDL-TG可以预测心血管事件的发生

2018-07-08

zhwj (审核中...)

前往app查看评论内容

#LDL#

OCC2018 | 梁春：独立于降低LDL-C的抗炎治疗，开启抗动脉粥样硬化精准治疗新纪元——CANTOS研究解读

2018-06-06

zhwj (审核中...)

前往app查看评论内容

#LDL#

Circulation：必须对LDL-C下狠手了！迄今很大、亚洲临床研究证实，高剂量他汀对亚洲人心血管疾病的二级预防更有效

2018-05-10

zhwj (审核中...)

前往app查看评论内容

#LDL#

JAMA：基线LDL水平影响调脂药物的疗效

2018-05-09

科室
- - 订阅+
  - 更多科室
工具
服务